These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30444309)
1. Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy. Evers PD; Alsaied T; Anderson JB; Cnota JF; Divanovic AA Congenit Heart Dis; 2019 Mar; 14(2):221-229. PubMed ID: 30444309 [TBL] [Abstract][Full Text] [Related]
2. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471 [TBL] [Abstract][Full Text] [Related]
3. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Mevorach D; Elchalal U; Rein AJ Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center. Krishnan A; Arya B; Moak JP; Donofrio MT Prenat Diagn; 2014 Dec; 34(12):1207-12. PubMed ID: 24989941 [TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Saleeb S; Copel J; Friedman D; Buyon JP Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029 [TBL] [Abstract][Full Text] [Related]
8. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block. Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310 [TBL] [Abstract][Full Text] [Related]
9. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173 [TBL] [Abstract][Full Text] [Related]
10. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen. Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218 [TBL] [Abstract][Full Text] [Related]
18. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Gleicher N; Elkayam U Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701 [TBL] [Abstract][Full Text] [Related]